GeneralInformation
Immunogen
Epstein-barr virus (ebv) particles
Fusion Species
Mouse X Mouse Hybridoma
Immunological Donor
BALB/c mouse spleen
Cell Line Description
Established by fusion of the P3X62AG8.653 mouse myeloma cell line with spleen cells of a BALB/c mouse immunized with Epstein-Barr virus (EBV) particles; cells produce a monoclonal antibody (igg1) that reacts with a viral envelope glycoprotein (350/220 kd) and that neutralizes EBV confirmed as mouse with IEF of AST, MDH, PEP B. .
Viruses: ELISA: reverse transcriptase positive; PCR: SMRV
Morphology
single cells in suspension
Growth Properties
suspension
CultureMethod
Subculturing
Split ratio: 1:3 to1: 5, every 2-3 days; seed out at 0.1-1.0 x 10^6 cells/ml; Harvest: maximal density of about 1.0-1.5 x 10^6 cells/ml.
Storage
Liquid nitrogen vapor phase.
Freezing medium: to complete growth medium(20%FBS), add 10%(v/v) DMSO
Citations
Have you cited CSC-H1427 in a publication?
Let us know and earn a reward for your research.
Product Name |
Cat. No. |
Applications |
Host Species |
Datasheet |
Price |
Add to Basket |
Product Name |
Cat. No. |
Applications |
Host Species |
Datasheet |
Price |
Add to Basket |
Croia, C; Serafini, B; et al. Epstein-Barr virus persistence and infection of autoreactive plasma cells in synovial lymphoid structures in rheumatoid arthritis. ANNALS OF THE RHEUMATIC DISEASES 72:1559-1568(2013).
Casabonne, D; Benavente, Y; et al. Aberrant Epstein-Barr virus antibody patterns and chronic lymphocytic leukemia in a Spanish multicentric case-control study. INFECTIOUS AGENTS AND CANCER 10:-(2015).